Login to Your Account

ISTA Receives Approval For Vitrase As Spreading Agent

By Kim Coghill

Friday, May 7, 2004
ISTA Pharmaceuticals Inc. won FDA approval of Vitrase for use as a spreading agent to facilitate the dispersion and absorption of other drugs. Meanwhile, the firm is awaiting approval on an earlier new drug application for Vitrase as a single injection to the eye for vitreous hemorrhage. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription